Patent Landscape & Technical IP Report for Antibody Antigen based Medical Diagnostic Kits filed in India

Patent Landscape & Technical
IP Report for Antibody- Antigen
Based Medical Diagnostic Kits
Filed in India

List of Granted & Pending Patents before the
Indian Patent Office relating to Antibody
based Inventions including diagnostic kits,
process and methods to test the disease.

Granted Patents in Medical Device Sector in India
Antibody therapy based invention titled “ANTI-TRKA ANTIBODY” was granted a
patent by the Indian Patent Office (IPO) to LAY LINE GENOMICS S.P.A on
21/02/2014. The patent application was filed on /09/2010 bearing patent
application number 1861/MUMNP/2010 before the Indian Patent Office.
Field of invention identified by the patent examiner relates to field of (FI17)
MICROBIOLOGY. The identified IPC for the invention is C07K16/28, A61K39/395,
A61P25/00.
www.techcorplegal.com | Patent your Invention, Idea, & Innovation | Patent Validity Search or Patent Invalidity Services

ANTI-TRKA ANTIBODY
Antibodies and derivatives there of. An anti-TrkA antibody is provided that
comprises:
a) a variable heavy chain comprising a sequence selected from any of BXhVHl,
BXhVH2, BXhVH3, BXhVH4, BXhVH5, or HuVHWOv as shown in Figure la; or
from variants of any of said sequences and/or b) a variable light chain comprising
a sequence selected from any of BXhVLl, BXhVL2, BXhVL3, BXhVL4, BXhVL5,
BXhVL6, BXhVL7 or BXhVL8; as shown in Figure lb, or from variants of any of
said sequences.
TrkA-binding derivatives are also provided. Antibodies or derivatives of the present
invention are useful in a number of therapies, including pain therapy.

Granted Patents in Medical Device Category in India
Medical diagnostic invention titled “A SYSTEM FOR DETECTING PATHOGENS
USING MICROBEADS CONJUGATED TO BIORECOGNITION MOLECULES”
was granted a patent by the Indian Patent Office (IPO) to FIO CORPORATION on
15/04/2016. The patent application was filed on 11/09/2008 16:06:14 bearing
patent application number 7695/DELNP/2008 before the Indian Patent Office.
MICROBIOLOGY. The identified IPC for the invention is C12Q1/04.

A SYSTEM FOR DETECTING PATHOGENS USING MICROBEADS
CONJUGATED TO BIORECOGNITION MOLECULES
A method and system are provided for the simultaneous detection and
identification of multiple pathogens in a patient sample. The sample is combined
with microbeads, which have been injected with quantum dots or fluorescent
dye and conjugated to pathogen-specific biorecognition molecules, such as
antibodies and oligonucleotides.
Treatment options may be determined based on the identities of the pathogens
detected in the sample.

Granted
Patents in
Medical
Device
Category in
India
Test based invention titled “HIGH THROUGHPUT
TESTING FOR PRESENCE OF
MICROORGANISMS IN A BIOLOGICAL SAMPLE”
was granted a patent by the Indian Patent Office
(IPO) to STIRUS GLOBAL SOLUTIONS LIMITED
on 04/04/2014. The patent application was filed on
22/08/2008 bearing patent application number
7202/DELNP/2008 before the Indian Patent Office.
Field of invention identified by the patent examiner
relates to field of (FI17) MICROBIOLOGY. The
identified IPC for the invention is C12Q-1/68

HIGH THROUGHPUT TESTING FOR PRESENCE OF MICROORGANISMS IN A
BIOLOGICAL SAMPLE
Provided are methods and apparatus for high throughput testing of biological
samples that may or may not comprise microorganisms. The methods include the
use of a diagnostic multiplexing panel (DMP) specifically designed for the
simultaneous identification of a plurality of potential microorganisms that may be
present in the biological sample via a primer extension reaction directed a highly
conserved nucleic acid sequences in the microorganisms under test. The
biological sample is typically immobilised on a solid substrate at a first location
before being transferred to a second location for analysis using the DMP. The
methods and apparatus of the invention are particularly suited to diagnosis of the
presence of infectious pathogens in the biological sample, for example for
diagnosis of sexually transmitted infection. Figure 1 is the representative Figure.

Invention titled “A COMPOSITION COMPRISING A
PHOSPHATIDYLETHANOLAMINE BINDING PEPTIDE CONJUGATE” was
granted a patent by the Indian Patent Office (IPO) to BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM on 23/08/2013. The patent application was filed
on 04/01/2008 bearing patent application number 130/DELNP/2008 before the
Indian Patent Office.
BIOTECHNOLOGY. The identified IPC for the invention is C07K16/00.

A COMPOSITION COMPRISING A PHOSPHATIDYLETHANOLAMINE BINDING
PEPTIDE CONJUGATE
Disclosed are surprising discoveries concerning the role of anionic phospholipids
and amino phospholipids in tumor vasculature and in viral entry and spread, and
compositions and methods for utilizing these findings in the treatment of cancer
and viral infections.
Also disclosed are advantageous antibody, immunoconjugate and
duramycin-based compositions and combinations that bind and inhibit anionic
phospholipids and amino phospholipids, for use in the safe and effective treatment
of cancer, viral infections and related diseases.

Invention titled “ANTIBODIES OR FRAGMENTS THEREOF HAVING
SCLEROSTIN BINDING AND SCLEROSTIN NEUTRALIZING ACTIVITY” was
granted a patent by the Indian Patent Office (IPO) to 1.AMGEN INC. 2. UCB
PHARMA S.A. on 25/09/2015. The patent application was filed on 02/11/2007
bearing patent application number 4223/KOLNP/2007 before the Indian Patent
Office. Field of invention identified by the patent examiner relates to field of (FI02)

ANTIBODIES OR FRAGMENTS THEREOF HAVING SCLEROSTIN BINDING
AND SCLEROSTIN NEUTRALIZING ACTIVITY
Compositions and methods relating to epitopes of sclerostin protein, and sclerostin
binding agents, such as antibodies capable of binding to sclerostin, are provided.

Medical kit based invention titled “SYNTHETIC PEPTIDE DERIVED FROM HIV
GAG P24 PROTEIN, ANTIGEN, VACCINE COMPOSITION AND KIT THEREOF”
was granted a patent by the Indian Patent Office (IPO) to BIONOR IMMUNO AS
on 06/01/2012. The patent application was filed on 11/09/2007 bearing patent

SYNTHETIC PEPTIDE DERIVED FROM HIV GAG P24 PROTEIN, ANTIGEN,
VACCINE COMPOSITION AND KIT THEREOF
The present invention comprises novel and modified peptides capable of inducing
an HIV-1 specific immune response without antagonizing the cytotoxic T-cell
activity in order to achieve an effective prophylactic and therapeutic vaccine
against HIV. The peptides are based on conserved regions of HIV gag p24
proteins. Antigens in free or carrier-bound form comprising at least one of the said
peptides, vaccine compositions containing at least one of the antigens,
immunoassay kits and a method of detecting antibodies induced by HIV or HIV
specific peptides using such antigens, are described.

Invention titled “A SYNTHETIC PEPTIDE” was granted a patent by the Indian
Patent Office (IPO) to BIONOR IMMUNO AS on 06/07/2012. The patent
application was filed on 11/09/2007 bearing patent application number
1391/MUMNP/2007 before the Indian Patent Office.
BIOTECHNOLOGY. The identified IPC for the invention is C07K-14/16.

A SYNTHETIC PEPTIDE
proteins. Antigens in free- or carrier-bound form comprising at least one of the said

Peptide based invention titled “PEPTIDE OF SEQ ID NO. 15 DERIVED FROM
HIV GAG P24 PROTEIN, ANTIGEN AND VACCINE COMPOSITION THEREOF”
was granted a patent by the Indian Patent Office (IPO) to BIONOR IMMUNO AS
on 01/04/2011. The patent application was filed on 11/09/2007 bearing patent
BIOTECHNOLOGY. The identified IPC for the invention is C07K-14/16

PEPTIDE OF SEQ ID NO. 15 DERIVED FROM HIV GAG P24 PROTEIN,
ANTIGEN AND VACCINE COMPOSITION THEREOF
proteins. Antigens in free- or carrier-bound form comprising at least one of the said

Biotech invention titled “A PLASMID COMPRISING, AS THE SOLE YEAST
SELECTABLE MARKER,A GENE ENCODING A CHAPERONE,A HOST CELL
COMPRISING IT AND A METHOD OF PRODUCING...PROTEIN” was granted a
patent by the Indian Patent Office (IPO) to NOVOZYMES BIOPHARMA DK A/S on
09/09/2011. The patent application was filed on 25/06/2007 bearing patent
application number 2783/CHENP/2007 before the Indian Patent Office. Field of
invention identified by the patent examiner relates to field of (FI02)
BIOTECHNOLOGY. The identified IPC for the invention is C12N15/81.

A PLASMID COMPRISING, AS THE SOLE YEAST SELECTABLE MARKER,A
GENE ENCODING A CHAPERONE,A HOST CELL COMPRISING IT AND A
METHOD OF PRODUCING PROTEIN
The present invention provides a method for producing a desired protein (such as
a desired heterologous protein) comprising: (a) providing a host cell comprising a
first recombinant gene encoding a protein comprising the sequence of a first
chaperone protein, a second recombinant gene encoding a protein comprising
the sequence of a second chaperone protein and a third gene, such as a third
recombinant gene, encoding a desired protein (such as a desired heterologous
protein), wherein the first and second chaperones are different; and (b) culturing
the host cell in a culture medium to obtain expression of the first, second and third
genes.

Granted Patents in Pharma Sector in India
Invention titled “MODAFINIL MODIFIED RELEASE PHARMACEUTICAL
COMPOSITIONS” was granted a patent by the Indian Patent Office (IPO) to
CEPHALON, INC on 31/12/2010. The patent application was filed on 04/04/2006
bearing patent application number 812/KOLNP/2006 before the Indian Patent
Office.
PHARMACEUTICALS. The identified IPC for the invention is A61K-9/20, &
A61K-9/26.

MODAFINIL MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS
Pharmaceutical compositions comprising modafinil. The pharmaceutical
compositions can have a release profile which is different than that of traditional
pharmaceutical compositions of modafinil.

Invention titled “A PURIFIED PROTEIN COMPRISING PHOSPHODIESTERASE
(PDE) CATALYTIC DOMAIN OR LEISHMANIA-PED-B1 AND USES THEREOF”
was granted a patent by the Indian Patent Office (IPO) to UNIVERSITY OF BERN
& OTSUKA PHARMACEUTICAL CO., LTD. on 14/01/2011. The patent application
was filed on 30/03/2006 bearing patent application number 773/KOLNP/2006
before the Indian Patent Office.
Field of invention identified by the patent examiner relates to field of
BIOTECHNOLOGY. The identified IPC for the invention is C07K-14/44.

A PURIFIED PROTEIN COMPRISING PHOSPHODIESTERASE (PDE)
CATALYTIC DOMAIN OR LEISHMANIA-PED-B1 AND USES THEREOF
The present invention relates to novel amino acid and nucleic amino acid add
nucleic acid sequences of cyclic nucleotide-Specific phos-phodiesterses from the
parsite Lelskmmifa major. The invention also relates let nucleic acid consumers,
vectors, and host cells comprising the nucleic acid sequences as we'll as method
for producing and using the amino acid and nucleic and sequences. The invention
further relates to the use of these sequences , and of antibodies directed against
these.sequences, in the diagnosis treatment of disorders to the infection of Last
Monio major; including the identification of compounds than form complexes with
the polypeptides and nucleic acids of the present invention.

Invention titled “D-AMINO ACID PEPTIDES” was granted a patent by the Indian
Patent Office (IPO) to IMMUNOMEDICS INC on 13/02/2009. The patent
125/CHENP/2006 before the Indian Patent Office.
Field of invention identified by the patent examiner relates to field of
BIOCHEMISTRY. The identified IPC for the invention is C07K38/12.

D-AMINO ACID PEPTIDES
The present invention provides compounds of the formula X-Rl-D-[Dpr, Orn or Lys](A)-R2(Z)-D-[Dpr, Orn
or Lys](B)-R3(Y)-NR4R5; or Rl(X)-D-[Dpr, Orn or Lys](A)-R2(Z)-D-[Dpr, Orn or Lys](B)-R3(Y)-NR4R5, in
which X is a hard acid cation chelator, a soft acid cation chelator or Ac-, Rl, R2 and R3 are independently
selected from a covalent bond or one or more D-amino acids that can be the same or different, Y is a hard
acid cation chelator, a soft acid cation chelator or absent, Z is a hard acid cation chelator, a soft acid
cation chelator or absent, and A and B are haptens or hard acid cation chelators and can be the same or
different, and R4 and R5 are independently selected from the group consisting of hard acid cation
chelators, soft acid cation chelators, enzymes, therapeutic agents, diagnostic agents and H.
The present invention also provides methods of using these compounds and kits containing the
compounds.

Invention titled “A PROCESS FOR PREPARING PURE ARABINOSYL ATED
LIPOARABINOMANNAN EFFECTIVE AGAINST TUBERCULOSIS AND
LEISHMANIASIS” was granted a patent by the Indian Patent Office (IPO) to BOSE
INSTITUTE on 15/01/2010. The patent application was filed on 23/08/2005
bearing patent application number 772/KOL/2005 before the Indian Patent Office.
CHEMICAL. The identified IPC for the invention is A61K-39/04.

A PROCESS FOR PREPARING PURE ARABINOSYLATED LIPOARABINOMANNAN EFFECTIVE
AGAINST TUBERCULOSIS AND LEISHMANIASIS
Resurgence of Tuberculosis Mycobacteria resistant to Isoniazid (INH), PAS and
even Streptomycin (SM), and the parasite Leishmania donovani resistant to
classical antimonial drug SAG (sodium antimony gluconate) have been posing
problems, which have been claiming human lives, particularly in developing and
underdeveloped countries. This invention attempts to provide a therapeutic tool to
treat both Tuberculosis and Leishmaniasis and resides in a process for preparing
a glycolipid Ara-LAM in pure form which comprises isolating Ara-LAM from
Mycobacterium smegmatis, performing SDS- PAGE and silver staining showing
the specific 37 kDa band of Ara-LAM.

A PROCESS FOR PREPARING PURE ARABINOSYLATED LIPOARABINOMANNAN EFFECTIVE
AGAINST TUBERCULOSIS AND LEISHMANIASIS
Followed by purification characterized by (i) dialyzing overnight in PBS and
lyophilizing to dryness; (ii) dissolving the resulting powder in sterile PBS; (iii)
loading the solution in 50 ml Sephacryl-200 column and eluting with PBS
(Phosphate Buffer Saline) at pH 7.4; (iv) collecting the eluted fractions showing
maximum peak (through carbohydrate estimation by phenol-sulphuric acid
method) and lyophilizing the same; (v) repeating the step of column
chromatography using Tris Buffer containing 10 mM Tris and 0.15 NaC1 as eluent
at pH 7.4; (vi) collecting the eluted fractions showing maximum peak and
lyophilizing the same; (vii) dissolving the lyophilized powder in sterile double
distilled water; (viii) storing the solution at a low temperature of around -40°C for
further use and, if desired, (ix) converting the aqueous solution into orally or
intraperitoneally administrable vaccine by standard procedure.

Invention titled “MODULAR ANTIGEN TRANSPORTER MOLECULES (MAT
MOLECULES) FOR MODULATING IMMUNE REACTIONS, ASSOCIATED
CONSTRUCTS” was granted a patent by the Indian Patent Office (IPO) to
IMVISION GMBH on 31/03/2008. The patent application was filed on 10/05/2005
bearing patent application number 397/MUMNP/2005 before the Indian Patent
Office.
BIOCHEMISTRY.

MODULAR ANTIGEN TRANSPORTER MOLECULES (MAT MOLECULES) FOR
MODULATING IMMUNE REACTIONS, ASSOCIATED CONSTRUCTS
A modular antigen transport molecule (MAT molecule) at least consisting of at
least one translocation module, at least one targeting module and at least one
antigen molecule, where
a)the translocation module is a molecular unit which brings about transport of the
MAT molecule from the extracellular space into the interior of the cell.,
b) the targeting module is a molecular unit which brings about transport of the
MAT molecule intracellularly to the organelles which are involved in the processing
of antigens or the loading of MHC molecules with antigens, and
c) the antigen module is a molecular unit which at least consists of one antigen
and which determines the specificity of an immune response modulated by the
MAT molecule in an individual.

Invention titled “A COMPOUND OR A TARGETABLE CONSTRUCT FOR
THERAPEUTIC USE” was granted a patent by the Indian Patent Office (IPO) to
IMMUNOMEDICS INC on 21/09/2007. The patent application was filed on
13/12/2004 bearing patent application number 2815/CHENP/2004 before the
BIOTECHNOLOGY. The identified IPC for the invention is A61K-47/48.

A COMPOUND OR A TARGETABLE CONSTRUCT FOR THERAPEUTIC USE
The present invention relates to targetable constructs which may be bound by a
bispecific antibody or antibody fragment having at least one arm that specifically
binds a targeted tissue and at least one other arm that specifically binds the
targetable construct. The targetable construct comprises a carrier portion which
comprises or bears at least one epitope recognizable by at least one arm of said
bispecific antibody or antibody fragment.
The targetable construct further comprises one or more therapeutic or diagnostic
agents or enzymes. The invention provides constructs and methods for producing
the targetable constructs and bi-specific antibodies or antibody fragments, as well
as methods for using them.

Invention titled “A NOVEL CONJUGATE” was granted a patent by the Indian
Patent Office (IPO) to MOLMED SPA on 04/07/2008. The patent application was
filed on 29/10/2004 bearing patent application number 2465/CHENP/2004 before
the Indian Patent Office.
BIOCHEMISTRY. The identified IPC for the invention is A61K-47/48.

A NOVEL CONJUGATE
A conjugate of il-12 and at least one tumor targeting moiety
containing the NGR motif.

Method invention titled “PROCESS FOR THE ISOLATION AND PURIFICATION
OF HIGHER YIELD OF PROTEIN P17 OF HIV-1(SUBTYPE C)(A NON LIVING
PROTEIN)” was granted a patent by the Indian Patent Office (IPO) to
DEPARTMENT OF BIOCHEMISTRY,DELHI UNIVERSITY on 26/11/2010. The
patent application was filed on 16/06/2003 bearing patent application number
808/DEL/2003 before the Indian Patent Office. Field of invention identified by the
patent examiner relates to field of (FI03) CHEMICAL. The identified IPC for the
invention is A61K-48/00.
.techcorplegal.com | Patent your Invention, Idea, & Innovation | Patent Validity Search or Patent Invalidity Services

PROCESS FOR THE ISOLATION AND PURIFICATION OF HIGHER YIELD OF
PROTEIN P17 OF HIV-1(SUBTYPE C)(A NON LIVING PROTEIN)
A simple and efficient method for hyper-expression in Escherichia coli and
purification of matrix protein, p17, of human immunodeficiency virus type 1
(HTV-1) of both B- and C-subtypes is described. DNA sequences encoding p1 7.
of B-and C-subtype were cloned from respective gag sequences. The gag
sequences were obtained by PCR amplification using DNA extracted from
peripheral blood lymphocytes of an HTV-1 infected patient from India. DNA
sequence analysis revealed that die sample contained gag sequences of both
HTV-1 B and C subtypes indicating dual infection.

PROCESS FOR THE ISOLATION AND PURIFICATION OF HIGHER YIELD OF
PROTEIN P17 OF HIV-1(SUBTYPE C)(A NON LIVING PROTEIN)
A T7 promoter based expression system was optimised for hyper-expression of
pl7 iri the soluble form-Both pl7 (B- and C-subtype) were purified to near
homogeneity using conventional chromatographic techniques. Purification of pl7
(C subtype) was described for the first time with yield of 7.7 mg from one litre
culture. The yield of pl7 (B subtype) was 14.7 mg from one litre culture, which was
several folds better than reported earlier. The immunoreactivity of both types of pl7
to sera from HTV infected individuals was comparable. The method described
here provides large quantities of highly pure pl7 of both B and C subtype, which
can be used for structural, biochemical and immunologic^ characterization and,
eventually for diagnostic and prognostic applications.

Peptide invention titled “PEPTIDE DERIVED FROM HIV-1 GAG P17 PROTEIN,
ANTIGEN AND VACCINE COMPOSITION” was granted a patent by the Indian
Patent Office (IPO) to BIONOR IMMUNO AS, on 24/10/2008. The patent
00296/DELNP/2003 before the Indian Patent Office.
PHARMACEUTICALS.

PEPTIDE DERIVED FROM HIV-1 GAG P17 PROTEIN, ANTIGEN AND VACCINE
COMPOSITION
a HIV-1 specific immune response without antagonizing the cytotoxic T-cell activity
in order to achieve an effective prophylactic and therapeutic vaccine against HIV.
The peptides are based on conserved regions of HIV gag p17 and p24 proteins.
Antigens in free- or carrier-bound form comprising at least one of the said

Invention titled “PEPTIDE DERIVED FROM HIV-1 REGULATORY PROTEIN,
ANTIGENS HAVING SAID PEPTIDES AND VACCINE COMPOSITION OF SAID
ANTIGEN” was granted a patent by the Indian Patent Office (IPO) to BIONOR
IMMUNO AS on 31/07/2009. The patent application was filed on 03/03/2003
bearing patent application number 00285/DELNP/2003 before the Indian Patent
Office.

PEPTIDE DERIVED FROM HIV-1 REGULATORY PROTEIN, ANTIGENS
HAVING SAID PEPTIDES AND VACCINE COMPOSITION OF SAID ANTIGEN
a HlV-1 specific immune response without aniagon ing: the cytotoxic T-cell activity
in order to achieve an effective prophylactic and ihcrapcuiic vaccine apainsi IMV,
The peptides. arc based on Conserved regions of IPV Tai and Ruv. ruguiaiory
protein and NCF auxiliary proteins. Antigens in lron-or-or carrier-hound 1'orm
comprising at least one of the said peptides, vaccine compositions containing ui
leasi one of the antigens, immunoassay kits and a method of detecting antibodies
induced by HIV or HTV specific peptides using such antigens, arc described.

Invention titled “A POLYNUCLEOTIDE HAVING THE NUCLEIC ACID
SEQUENCE ACCORDING TO SEQ ID NO:1, 2 OR 3 OR A SEQUENCE FROM
THE NUCLEOTIDE NUMBERS” was granted a patent by the Indian Patent Office
(IPO) to GENEART AG on 12/03/2010. The patent application was filed on
23/04/2002 bearing patent application number IN/PCT/2002/507/KOL before the
BIOTECHNOLOGY. The identified IPC for the invention is C12N-15/49

A POLYNUCLEOTIDE HAVING THE NUCLEIC ACID SEQUENCE ACCORDING
TO SEQ ID NO:1, 2 OR 3 OR A SEQUENCE FROM THE NUCLEOTIDE
NUMBERS
A polynucleotide having the nucleic acid sequence according to SEQ ID NO:1, 2
or 3 or a sequence from the nucleotide numbers 167 to 1654, 1447 to 4458, 5589
to 8168, 4403 to 4984, 4924 to 5214, 5426 to 5671, 8170 to 8790, 5195 to 5409,
7730 to 7821, 5334 to 5409 or 7730 to 7821, or a continuous sequence on a
polynucleotide from the nucleotide numbers 5195 to 5409 and 7730 to 7821, or
5334 to 5409 and 7730 to 7821, each referring to SEQ ID NO:1.

Invention titled “PEPTIDE DERIVED FROM HIV GAG P24 PROTEIN AND
ANTIGEN, VACCINE COMPOSITION AND IMMUNOASSAY KIT COMPRISING
THE SAME” was granted a patent by the Indian Patent Office (IPO) to BIONOR
IMMUNO AS on 15/08/2008. The patent application was filed on 30/08/2001
bearing patent application number IN/PCT/2001/01023/MUM before the Indian
Patent Office.
PHARMACEUTICALS. The identified IPC for the invention is C07K14/16

PEPTIDE DERIVED FROM HIV GAG P24 PROTEIN AND ANTIGEN, VACCINE
COMPOSITION AND IMMUNOASSAY KIT COMPRISING THE SAME
PEPTIDE DERIVED FROM HIV gag p24 PROTEIN AND ANTIGEN, VACCINE
COMPOSITION AND IMMUNOASSAY KIT COMPRISING THE SAME" The
present invention relates to peptide derived from HIV gag p24 protein,
characterized in that it comprises a modified amino acid sequence containing
modifications compared to the native sequence and selected from the amino acid
sequence ID. NO. 3, the terminal ends of the sequences may be free carboxyl- or
amino groups, amides, acyls, acetyls or salts thereof, two or more of the C ys
residues may form part of an intrachain- or interchain disulphide binding, a
-S-(CH2)p-S- or a -(CH2)p-bridge wherein p = 1-8 optionally intervened by one or
more heteroatoms such as O, N and S and/or the said peptide sequences are
immobilized to a solid support. The present invention also relates to antigen,
vaccine composition and immunoassay kit comprising the said peptide.

Patent Application
Number
Patent Title Patent
Application Date
in India
Current Patent Status
in India
201618022317 Targeting Lipids 2016/06/29 Published
201617007938
OLIGONUCLEOTIDE PROBES
AND USES THEREOF
2016/03/07 Published
201617006126
CLAMP DEVICE FOR
MINIMALLY INVASIVE
PROCEDURES AND USES
THEREOF

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1981/KOLNP/2015
ANTIBODIES OR
FRAGMENTS THEREOF
HAVING SCLEROSTIN
BINDING AND SCLEROSTIN
NEUTRALIZING ACTIVITY
5326/DELNP/2015
CHLORIN DERIVATIVE
USEFUL IN PHOTODYNAMIC
THERAPY AND DIAGNOSIS
3376/DELNP/2015
APTAMERS AND USES
THEREOF

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
2769/KOLNP/2014
PEPTIDES DERIVED FROM
VIRAL PROTEINS FOR USE AS
IMMUNOGENS AND DOSAGE
REACTANTS
4012/CHE/2014
FABRIC BASED MULTIPLEXED
IMMUNOASSAY DEVICES FOR
RAPID DIAGNOSTIC TESTING
2385/MUM/2014
A DIAGNOSTIC APPARATUS
FOR TESTING AND EARLY
DETECTION OF HIV (HUMAN
IMMUNODEFICIENCY VIRUS)
VIRUS.

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
3072/CHE/2014
METHODS OF UPSCALING
MESENCHYMAL STROMAL
CELL PRODUCTION,
COMPOSITIONS AND KIT
THEREOF
1188/MUMNP/2014
ANTI ADRENOMEDULLIN
(ADM) ANTIBODY OR ANTI
ADM ANTIBODY FRAGMENT
OR ANTI ADM NON IG
SCAFFOLD FOR USE IN
THERAPY OF AN ACUTE
DISEASE OR ACUTE
CONDITION OF A PATIENT
FOR STABILIZING THE
CIRCULATION

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1192/MUMNP/2014
ANTI ADRENOMEDULLIN
OR ANTI ADM NON IG
SCAFFOLD FOR REGULATING
THE FLUID BALANCE IN A
PATIENT HAVING A CHRONIC
OR ACUTE DISEASE
1191/MUMNP/2014
ANTI ADRENOMEDULLIN
OR AN ANTI ADM NON IG
SCAFFOLD FOR USE IN
THERAPY

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1189/MUMNP/2014
ANTI ADRENOMEDULLIN
OR ANTI ADM NON IG
SCAFFOLD FOR PREVENTION
OR REDUCTION OF ORGAN
DYSFUNCTION OR ORGAN
FAILURE IN A PATIENT
HAVING A CHRONIC OR
ACUTE DISEASE OR ACUTE
CONDITION
2611/CHE/2014
DIAGNOSTIC TEST KIT FOR
MULTIANALYTE DETECTION

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
10070/DELNP/2013
MODIFIED BIOTIN BINDING
PROTEIN FUSION PROTEINS
THEREOF AND APPLICATIONS
10065/DELNP/2013
MULTIPLE ANTIGEN
PRESENTING IMMUNOGENIC
COMPOSITION AND METHODS
AND USES THEREOF
3367/DEL/2013
HERBAL TOOTHPASTE FOR
PROTECTION OF TOTAL ORAL
HEALTH

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1912/KOLNP/2013
MONOMERIC AND
MULTIMERIC
IMMUNOGENIC PEPTIDES
1697/MUM/2013
RAPID DETECTION OF
CANDIDA SPECIES OR
PATHOGENS AND TOXIN BY
LESS CYCLE OF
BIOCONJUGATE-NANO-PCR
889/MUMNP/2013
COMPOSITIONS AND
METHODS FOR ACTIVATING
EXPRESSION BY A
SPECIFIC ENDOGENOUS
MIRNA

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1965/CHENP/2013
HUMAN FACILITATING
CELLS AND USES
THEREOF
9304/CHENP/2012
ALBUMIN DERIVATIVES
AND VARIANTS
6295/DELNP/2012
CD20 ANTIBODIES AND
USES THEREOF

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
4511/DELNP/2012
"ORGANIC COMPOSITIONS TO
TREAT HSF1-RELATED
DISEASES"
3728/CHENP/2012
DIAGNOSTIC GEL
COMPOSITION METHOD
FOR MAKING A
DIAGNOSTIC GEL
COMPOSITION
3492/DELNP/2012
A CYTOLYTIC RTX-TOXIN
FROM GALLIBACTERIUM
ANATIS

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
4749/KOLNP/2011
METHODS FOR IDENTIFICATION
OF SITES FOR IGG
CONJUGATION
8810/DELNP/2011 URINARY DEVICE 2011/11/12 Published
402/CHE/2011
TECHNOLOGY PLATFORM
USED TO DEVELOP
THERAPEUTIC VACCINES AND
DRUGS AGAINST HIV AND
OTHER AUTOIMMUNE
DISEASES

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
426/KOLNP/2011
ANTIBODIES DIRECTED
AGAINST PYROGLUTAMATE
MONOCYTE
CHEMOATTRACTANT
PROTEIN-1 (MCP-1-N1PE)
1429/KOL/2010
A CLIA KIT FOR THE EARLY
DETECTION OF IGM
ANTIBODIES TO
CHIKUNGUNYA PRESENT IN
HUMAN SERUM OR PLASMA
4543/KOLNP/2010
METHOD OF DIAGNOSIS OF
INFECTION BY
MYCOBACTERIA AND
REAGENTS THEREFOR

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
6298/DELNP/2010
SELECTED ANTIBODIES
BINDING TO ANIONIC
PHOSPHOLIPIDS &
AMINOPHOSPHOLIPIDS
AND THEIR USE IN
TREATING VIRAL
INFECTIONS AND CANCER
1861/MUMNP/2010
ANTI-TRKA ANTIBODIES
AND DERIVATIVES
THEREOF
1861/MUMNP/2010 ANTI-TRKA ANTIBODY 2010/09/01 Granted

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1909/CHE/2010
METHODS OF MAKING A DIAGNOSTIC
COMPOSITION AND COMPOSITIONS
THEREFROM
716/KOL/2010
AN IMPROVED CHEMILUMINESCENCE
IMMUNOASSAY KIT FOR SIMULTANEOUS
DETECTION OF HIV 1 AND HIV 2
ANTIBODIES AND HIV 1 P24 ANTIGEN IN
HUMAN SERUM AND PLASMA
681/KOL/2010
A FILTER DEVICE FOR THE SEPARATION
OF PLASMA OR SERUM FROM THE
WHOLE BLOOD FOR THE DIAGNOSTIC
ASSAY

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
3165/DELNP/2010
'FLOW FOCUSING METHOD
AND SYSTEM FOR FORMING
CONCENTRATED VOLUMES
OF MICROBEADS, AND
MICROBEADS FORMED
FURTHER THERETO'
2527/CHENP/2010
“ENGINEERED PERTACTIN
VARIANTS FOR VACCINE
USE”
1981/CHENP/2010
MIRNA EXPRESSION IN
HUMAN PERIPHERAL BLOOD
MICROVESICLES AND USES
THEREOF

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
2067/DELNP/2010
"COMPOSITION AND
METHODS USE FOR
ANTIBODIES AGAINST
SCLEROSTIN"
731/DELNP/2010 "ASSAYS" 2010/02/02 Published
8226/DELNP/2009
"METHODS AND
COMPOSITIONS FOR
TREATING ALLERGIC
DISEASES"

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
6866/DELNP/2009
“IMPRINTED POLYMERIC
MATERIALS FOR BINDING
VARIOUS TARGETS SUCH AS
VIRUSES”
4647/DELNP/2009
"MICROFLUIDIC SYSTEM AND
METHOD TO TEST FOR
TARGET MOLECULES IN A
BIOLOGICAL SAMPLE"
1578/MUM/2009
A DIAGNOSTIC KIT FOR
SIMULTANEOUS SCREENING
OF HIV-1 AND HIV-2
ANTIBODIES AND ANTIGENS
IN HUMAN SERUM AND
PLASMA

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
10654/DELNP/2008
"CD4 MIMIC PEPTIDES AND
THEIR USES"
4931/KOLNP/2008
GENE THERAPY FOR
AMYOTROPHIC LATERAL
SCLEROSIS AND OTHER
SPINAL CORD DISORDERS
2275/MUMNP/2008
APOLIPOPROTEIN
FINGERPRINTING
TECHNIQUE

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
7968/DELNP/2008
METHODS AND COMPOSITIONS
FOR HIGHLY SENSITIVE
ANALYSIS OF MARKERS AND
DETECTION OF MOLECULES
4878/CHENP/2008 AFFINITY REGIONS 2008/09/15 Published
7695/DELNP/2008
"METHOD FOR DETECTING
PATHOGENS USING
MICROBEADS CONJUGATED TO
BIORECOGNITION MOLECULES"

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
7695/DELNP/2008
"A SYSTEM FOR DETECTING
PATHOGENS USING
MICROBEADS CONJUGATED TO
BIORECOGNITION MOLECULES"
2008/09/11 Granted
7202/DELNP/2008
HIGH THROUGHPUT TESTING
FOR PRESENCE OF
MICROORGANISMS IN A
BIOLOGICAL SAMPLE
7202/DELNP/2008
HIGH THROUGHPUT TESTING
FOR PRESENCE OF
MICROORGANISMS IN A
BIOLOGICAL SAMPLE
2008/08/22 Granted

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1615/MUMNP/2008
COMPOUNDS FOR THE
INHIBITION OF INTEGRINS
AND USE THEREOF
1492/KOLNP/2008
MULTIPLE ANTIGENIC
PEPTIDE ASSAY FOR
DETECTION OF HIV OR SIV
TYPE RETROVIRUSES
2501/DELNP/2008
METHOD OF DIAGNOSIS OF
TUBERCULOSIS RELATED
IMMUNE RESTORATION
SYNDROME (IRS)

Patent
Application
Number
Patent Title Patent
Application Date
in India
in India
130/DELNP/2008
SELECTED ANTIBODIES AND DURAMYCIN
PEPTIDES BINDING TO ANIONIC
PHOSPHOLIPIDS AND AMINO
PHOSPHOLIPIDS AND THEIR USE IN
TREATING VIRAL INFECTIONS AND CANCER
130/DELNP/2008
"A COMPOSITION COMPRISING A
PHOSPHATIDYLETHANOLAMINE BINDING
PEPTIDE CONJUGATE"
2008/01/04 Granted
9025/DELNP/2007
"HIV PEPTIDES ANTIGENS, VACCINE
COMPOSITIONS, IMMUNOASSAY KIT AND
METHOD OF DETECTING ANTIBODIES
INDUCED BY HIV"

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
2249/MUM/2007
A QUALITATIVE IN VITRO
DIAGNOSTIC KIT FOR
SIMULTANEOUS DETECTION
OF ANTI-HIV AND HCV
ANTIBODIES AND HBsAg
ANTIGENS
2248/MUM/2007
A QUALITATIVE IN VITRO
DIAGNOSTIC KIT FOR
SIMULTANEOUS DETECTION
OF ANTI-HIV ANTIBODIES
AND HBsAg ANTIGENS
4223/KOLNP/2007 BINDING AGENTS 2007/11/02 Published

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
4223/KOLNP/2007
ANTIBODIES OR FRAGMENTS
THEREOF HAVING
SCLEROSTIN BINDING AND
SCLEROSTIN NEUTRALIZING
ACTIVITY
2007/11/02 Granted
1393/MUMNP/2007
HIV PEPTIDES OF SEQ ID NO.
4, ANTIGENS, VACCINE
COMPOSITIONS,
IMMUNOASSAY KIT AND A
METHOD OF DETECTING
ANTIBODIES INDUCED BY HIV
1393/MUMNP/2007
SYNTHETIC PEPTIDE DERIVED
FROM HIV GAG P24 PROTEIN,
ANTIGEN, VACCINE
COMPOSITION AND KIT
THEREOF
2007/09/11 Granted

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1392/MUMNP/2007
HIV PEPTIDES OF SEQ ID NO.
COMPOSITIONS,
METHOD OF DETECTING
1391/MUMNP/2007
HIV PEPTIDES OF SEQ ID NO
COMPOSITIONS,
METHOD OF DETECTING
1391/MUMNP/2007 A SYNTHETIC PEPTIDE 2007/09/11 Granted

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1392/MUMNP/2007
PEPTIDE OF SEQ ID NO. 15
DERIVED FROM HIV GAG
P24 PROTEIN, ANTIGEN
AND VACCINE
COMPOSITION THEREOF
2007/09/11 Granted
5739/DELNP/2007
FC FUSION CONSTRUCTS
BINDING TO
PHOSPHATIDYLSERINE AND
THEIR THERAPEUTIC USE
3059/CHENP/2007
CELL FREE BIOSYNTHESIS
OF HIGH-QUALITY NUCLEIC
& NBSP ACID AND USES
THEREOF

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
2783/CHENP/2007
GENE EXPRESSION
TECHNIQUE
2783/CHENP/2007
A PLASMID COMPRISING AS
THE SOLE YEAST SELECTABLE
MARKER,A GENE ENCODING A
CHAPERONE, A HOST CELL
COMPRISING IT AND A
METHOD OF PRODUCING
PROTEIN
2007/06/25 Granted
4296/DELNP/2007
"SUBSTITUTED
AMINOPYRIDINES AND USES
THEREOF"

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
1958/CHENP/2007
ANDROGRAPHOLIDE DERIVATIVES
TO TREAT VIRAL INFECTIONS
168/KOLNP/2007
METHOD FOR MODULATING GENE
EXPRESSION BY ALTERING THE
CPG CONTENT
2807/CHENP/2006
METHODS OF PREDICTING A
BENEFIT OF ANTIOXIDANT
THERAPY FOR PREVENTION OF
CARDIOVASCULAR DISEASE IN
HYPERGLYCEMIC PATIENTS

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
893/MUMNP/2006
"DISEASE MANAGEMENT
SYSTEM"
2065/DELNP/2006
LIPOSOMES AND
LIPOSOMAL COMPOSITIONS
FOR VACCINATION AND
DRUG DELIVERY
812/KOLNP/2006
MODAFINIL MODIFIED
RELEASE PHARMACEUTICAL
COMPOSITIONS

Patent Application
Number
Patent Title Patent
Application Date
in India
Current Patent
Status in India
1048/DELNP/2006
"METHOD FOR PRODUCTION OF
BIORESORBABLE MICROPARTICLES,
MICROPARTICLES THUS OBTAINED
AND USE THEREOF"

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
243/MUM/2006
ANTIGEN DETECTION
USING ANTIBODIES
488/DELNP/2006
"SPECIFIC HUMAN
ANTIBODIES"
485/DELNP/2006
"ANTIBODIES AND USES
THEREOF"

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
838/MUM/2005
A RAPID DIAGNOSTIC TEST
KIT
2968/DELNP/2005
CYCLOPROPYL BETA-AMINO
ACID DERIVATIVES
397/MUMNP/2005
MODULAR ANTIGEN
TRANSPORTER MOLECULES
(MAT MOLECULES) FOR
MODULATING IMMUNE
REACTIONS, ASSOCIATED
CONSTRUCTS

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
397/MUMNP/2005
MODULAR ANTIGEN
TRANSPORTER MOLECULES
(MAT MOLECULES) FOR
MODULATING IMMUNE
REACTIONS, ASSOCIATED
CONSTRUCTS
2005/05/10 Granted
175/DELNP/2005
"ANTIBODIES AND USES
THEREOF"
2815/CHENP/2004
A COMPOUND OR A
TARGETABLE CONSTRUCT
FOR THERAPEUTIC USE

Patent Application
Number
Patent Title Patent Application
Date in India
Current Patent
Status in India
2815/CHENP/2004
A COMPOUND OR A
TARGETABLE CONSTRUCT FOR
THERAPEUTIC USE
2004/12/13 Granted
2465/CHENP/2004 A NOVEL CONJUGATE 2004/10/29 Published

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
808/DEL/2003
" PROCESS FOR THE
ISOLATION AND
PURIFICATION OF HIGHER
YIELD OF PROTEIN P17 OF
HIV-1(SUBTYPE C)(A NON
LIVING PROTEIN)."
808/DEL/2003
" PROCESS FOR THE
ISOLATION AND
PURIFICATION OF HIGHER
YIELD OF PROTEIN P17 OF
HIV-1(SUBTYPE C)(A NON
LIVING PROTEIN)."
2003/06/16 Granted
00296/DELNP/2003
"PEPTIDE DERIVED FROM
HIV-1 GAG P17 PROTEIN,
ANTIGEN AND VACCINE
COMPOSITION"

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
00296/DELNP/2003
"PEPTIDE DERIVED FROM HIV-1
GAG P17 PROTEIN, ANTIGEN
AND VACCINE COMPOSITION"
2003/03/04 Granted
00285/DELNP/2003
''HIV REGULATORY AND
AUXILIARY PEPTIDES ANTIGENS
VACCINE COMPOSITIONS
METHOD OF DETECTING
ANTIBODIES INDUCED BY HIV"
00285/DELNP/2003
''PEPTIDE DERIVED FROM HIV-1
REGULATORY PROTEIN,
ANTIGENS HAVING SAID
PEPTIDES AND VACCINE
COMPOSITION OF SAID
ANTIGEN"
2003/03/03 Granted

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
IN/PCT/2002/1010/CHE
NUCLEIC ACIDS ENCODING
(POLY) PEPTIDES HAVING CHIPS
ACTIVITY
IN/PCT/2002/507/KOL
A POLYNUCLEOTIDE HAVING THE
NUCLEIC ACID SEQUENCE
ACCORDING TO SEQ ID NO:1, 2
OR 3 OR A SEQUENCE FROM THE
NUCLEOTIDE NUMBERS
2002/04/23 Granted
IN/PCT/2001/1639/CHE
METHOD FOR ENHANCED
PROTEIN STABILIZATION AND
PRODUCTION OF CELL LINES
USEFUL FOR PRODUCTION OF
SUCH STABILIZED PROTEINS

Patent Application
Number
Patent Title Patent
Application Date
in India
in India
IN/PCT/2001/01023/MUM
PEPTIDE DERIVED FROM
HIV GAG P24 PROTEIN
AND ANTIGEN, VACCINE
COMPOSITION AND
IMMUNOASSAY KIT
COMPRISING THE SAME
2001/08/30 Granted

Medical Diagnostic Patent Research Services | IP
Research & Technology Intelligence
We help our medical device clients with technology
intelligence services which is helpful to develop IP strategies.
In addition we provide research support to finalise the
prototype of the
Medical diagnostic kits.

Patent Landscape & Technical IP Report for Antibody Antigen based Medical Diagnostic Kits filed in India

Recommended

Recommended

More Related Content

Similar to Patent Landscape & Technical IP Report for Antibody Antigen based Medical Diagnostic Kits filed in India

Similar to Patent Landscape & Technical IP Report for Antibody Antigen based Medical Diagnostic Kits filed in India (20)

More from Prity Khastgir IPR Strategic India Patent Attorney Amplify Innovation

More from Prity Khastgir IPR Strategic India Patent Attorney Amplify Innovation (20)

Recently uploaded

Recently uploaded (20)

Patent Landscape & Technical IP Report for Antibody Antigen based Medical Diagnostic Kits filed in India